IMC-2C5 is a humanized antibody targeting PDGFRB/CD140b. IMC-2C5 binds with high affinity to PDGFRbeta and blocks its signaling pathway, thereby inhibiting tumor angiogenesis and stromal support, and exerting antitumor effects. IMC-2C5 is suitable for use in tumor research.
Reinheit:
100.00%
Target-Kategorie:
PDGFR
T9901A-227
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
